英文名稱 | PEAQX | NVP-AAM077 |
---|---|
中文名稱 | PEAQX | NVP-AAM077 |
CAS號(hào) | 459836-30-7 |
分子式 | C17H17BrN3O5P |
分子量 | 454.21 |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | PEAQX | NVP-AAM077 |
---|---|
中文名稱 | PEAQX | NVP-AAM077 |
CAS號(hào) | 459836-30-7 |
分子式 | C17H17BrN3O5P |
分子量 | 454.21 |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
PEAQX (NVP-AAM077) is an orally active and selective NMDA antagonist, with IC50 values of 270 nM and 29.6 μM for hNMDAR 1A/2A and hNMDAR 1A/2B, respectively. PEAQX can promote the activation of caspase-3 and induce cell apoptosis in cortical striatal slice cultures.
PMID: 28431607 DOI: 10.1016/j.jns.2017.03.027
PMID: 11909726 DOI: 10.1016/s0960-894x(02)00074-4
PMID: 19654040 PMCID: PMC2760688 DOI: 10.1016/j.neuroscience.2009.07.058